MedTrace Logo

Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention

NCT06148441 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-11-28

No results posted yet for this study

Summary

To study the relation between ISR and neutrophil-to-lymphocyte ratio (NLR), novel biomarkers (high-sensitivity CRP (hs-CRP), bone morphogenetic protein-2 (BMP-2) and other risk factors (age, sex, smoking, hypertension, diabetes, obesity, chronic kidney disease (CKD; creatinine clearance).

Conditions

  • In-stent Restenosis

Interventions

DIAGNOSTIC_TEST

bone morphogenetic protein-2 (BMP-2)

novel biomarkers associated with in-stent restenosis after percutaneous coronary intervention

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-01-31
Completion
2025-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06148441 on ClinicalTrials.gov